Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05213052
Other study ID # 173-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2021
Est. completion date May 1, 2022

Study information

Verified date May 2022
Source Natural Immune Systems Inc
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To perform a clinical proof-of-concept study on a novel topical formula for pain relief.


Description:

An open-label study where each participant will be involved in the study for 4 weeks. During the study participants will use the topical cream 1-2 times daily on the anatomical area(s) causing the most pain.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date May 1, 2022
Est. primary completion date February 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 75 Years
Eligibility Inclusion Criteria: - BMI between 18.5 and 34.9 kg/m2 (inclusive) - Chronic joint/muscle related pain for at least past 6 months - Experiencing chronic pain in at least one specific anatomical area for more than 6 months. Exclusion Criteria: - Cancer during past 12 months - Chemotherapy during past 12 months - Currently taking prescription pain medications - Getting regular joint injections (such as cortisone shots); - Immunization during last month - Participation in another clinical trial study during this trial, involving an investigational product or lifestyle change - Regularly experiencing headaches, including migraines - Serious active illness within past 6 months - Significant active uncontrolled illness (such as lymphoma, liver disease, kidney failure, heart failure). - Skin allergies related to ingredients in test product.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Topical cream
Topical cream applied to painful joint or muscle

Locations

Country Name City State
United States Gitte Jensen Klamath Falls Oregon

Sponsors (1)

Lead Sponsor Collaborator
Natural Immune Systems Inc

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Wellness Wellness questionnaire - Score 0-10 [0 being strongly disagree, 10 being strongly agree] 4 weeks
Primary Change in degree of pain Pain questionnaire - yes/no, score 0-24 hours 4 weeks
Secondary Activity level Activities of daily living questionnaire 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
Completed NCT05036499 - PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain N/A